Tag: Stentrode brain-computer interface
Synchron’s endovascular BCI achieves positive results in US COMMAND study
Synchron has announced positive results from the COMMAND study evaluating the safety and efficacy of the company’s Stentrode brain-computer interface (BCI) device in six...
Synchron announces US$10 million NIH grant for US COMMAND trial
The National Institutes of Health (NIH) has collectively awarded Carnegie Mellon University, University of Pittsburgh Medical Center (UPMC), Mount Sinai Health System and Synchron...
Synchron given green light to begin US study of endovascular brain-computer...
The Stentrode motor neuroprosthesis, developed by Synchron, has taken another step towards becoming the world’s first commercially available, endovascular brain-computer interface (BCI) technology after...
Stentrode brain-computer interface receives breakthrough device designation from FDA
The US Food and Drug Administration (FDA) has granted breakthrough device designation to the Stentrode brain-computer interface for its fully-implantable medical device that can...
